Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions

Figure 5

Example of difference in MLP controllability, for dry retinal conditions (subgroup 1) and for the presence of macular edema (subgroup 2). (a) Fundus photograph of the patient (subgroup 1), 30 minutes after MLP. (b) Fundus photograph of the patient (subgroup 2), 30 minutes after MLP. (c) B scan (through a photocoagulated region) of the patient of subgroup 1. (d) B scan (through a photocoagulated region) of the patient of subgroup 2. (e) En face image (at the level of the outer nuclear layer) of the patient of subgroup 1. (f) Retinal macular thickness map demonstrates either normal or decreased retinal thickness values in all ETDRS subfields in the patient of subgroup 1. (g) En face image (at the level of the outer nuclear layer) of the patient of subgroup 2. (h) Retinal macular thickness map demonstrates increased retinal thickness values in all ETDRS subfields in the patient of subgroup 2. (i) RM-SLO image of the patient (subgroup 1) 30 minutes after MLP. (j) RM-SLO image of the patient (subgroup 2) 30 minutes after MLP.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)